1248 related articles for article (PubMed ID: 26687571)
1. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
3. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies.
Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P
Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246
[TBL] [Abstract][Full Text] [Related]
5. The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.
Wetmore JB; Tang F; Sharma A; Jones PG; Spertus JA
Am Heart J; 2015 Oct; 170(4):735-43. PubMed ID: 26386797
[TBL] [Abstract][Full Text] [Related]
6. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
Peng F; Su J; Lin J; Niu W
J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization.
Alabdan N; Gosmanova EO; Tran NQ; Oliphant CS; Pan H; Broyles JE; Hudson JQ
Am J Med Sci; 2017 Feb; 353(2):172-177. PubMed ID: 28183419
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin-Aldosterone System Optimization for Acute Decompensated Heart Failure Patients (ROAD-HF): Rationale and Design.
Dass B; Dimza M; Singhania G; Schwartz C; George J; Bhatt A; Radhakrishnan N; Bansari A; Bozorgmehri S; Mohandas R
Am J Cardiovasc Drugs; 2020 Aug; 20(4):373-380. PubMed ID: 31797310
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
11. Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury.
Suberviola B; Rodrigo E; González-Castro A; Serrano M; Heras M; Castellanos-Ortega Á
Med Intensiva; 2017; 41(1):21-27. PubMed ID: 28341094
[TBL] [Abstract][Full Text] [Related]
12. Associations between preoperative continuation of renin-angiotensin system inhibitor and cardiac surgery-associated acute kidney injury: a propensity score-matching analysis.
Chou YH; Huang TM; Wu VC; Chen WS; Wang CH; Chou NK; Chiang WC; Chu TS; Lin SL;
J Nephrol; 2019 Dec; 32(6):957-966. PubMed ID: 31595420
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
14. Preoperative renin-angiotensin system inhibitors use linked to reduced acute kidney injury: a systematic review and meta-analysis.
Cheungpasitporn W; Thongprayoon C; Srivali N; O'Corragain OA; Edmonds PJ; Ungprasert P; Kittanamongkolchai W; Erickson SB
Nephrol Dial Transplant; 2015 Jun; 30(6):978-88. PubMed ID: 25800881
[TBL] [Abstract][Full Text] [Related]
15. Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.
Shen J; Huang YM; Song XN; Hong XZ; Wang M; Ling W; Zhang XX; Zhao HL
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27377659
[TBL] [Abstract][Full Text] [Related]
16. No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers.
Gilbert CJ; Gomes T; Mamdani MM; Hellings C; Yao Z; Garg AX; Wald R; Harel Z; Juurlink DN
Can J Cardiol; 2013 May; 29(5):586-91. PubMed ID: 23541666
[TBL] [Abstract][Full Text] [Related]
17. Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.
Goo JJ; Kim JJ; Kang JH; Kim KN; Byun KS; Kim MK; Kim TI
Korean J Intern Med; 2014 Mar; 29(2):203-9. PubMed ID: 24648803
[TBL] [Abstract][Full Text] [Related]
18. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
